FRSH (FRSH)
Quantitative Summary
DeterministicStrong operational fundamentals (Piotroski 7/9) with Altman Z of 0.4.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe capital allocation efficiency presents a critical divergence from the reported profitability metrics. Despite commanding robust gross margins of 85% and achieving net income growth that supports a Piotroski F-Score of 7/9, indicating strong financial health on an accrual basis, the return on invested capital stands at merely 1%. This creates a negative spread of -9.2% against a weighted average cost of capital of 10.1%, suggesting that while earnings are being generated efficiently in terms of margin and turnover, the underlying asset base is not yielding sufficient returns to cover the cost of equity and debt financing. The Altman Z-Score of 0.4 further flags potential distress risks despite the high Beneish M-Score of -2.29, which typically signals low earnings manipulation risk but may reflect aggressive accounting or specific industry dynamics that compress investment efficiency.
Valuation metrics appear compressed relative to the company's historical profitability profile and current growth trajectory. Trading at a forward P/E of 13.1x, the stock is priced significantly below its calculated DCF fair value of $29, implying the market may be discounting future cash flows heavily due to concerns regarding capital efficiency or solvency rather than earnings quality alone. This disparity suggests investors are pricing in a scenario where high margins and double-digit revenue growth fail to translate into sustainable economic returns on invested capital, potentially leaving room for re-rating if ROIC improves or if the cost of capital stabilizes below current levels.
The risk-reward landscape is bifurcated between fundamental distress signals and earnings integrity indicators. The low Altman Z-Score introduces significant bankruptcy risk considerations that likely anchor valuations lower than justified by pure earnings power, while the high Beneish M-Score offers some reassurance regarding the authenticity of reported net margins. Investors must weigh whether the current valuation gap reflects a temporary market overreaction to capital inefficiency or a structural inability for the business model to generate adequate returns on its asset base given the prevailing cost of capital.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 8.1% | 10.1% | 12.1% |
|---|---|---|---|
| 2% | $35 | $26 | $21 |
| 3% | $40 | $29 | $23 |
| 4% | $49 | $33 | $25 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=10.1%, terminal growth 3%. Fair value $29 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like XSW or VFQY, the fund manager is mechanically forced to buy or sell FRSH shares regardless of FRSH's individual fundamentals. We estimate $65M of passive capital is structurally linked to FRSH through 5 tracked ETFs. Passive flows have a limited but growing influence on FRSH's daily trading dynamics.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 5 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in FRSH to visualize passive redemption contagion across ETFs and collateral stocks.
If FRSH (FRSH) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies NVIDIA Corp. (NVDA) as the most exposed collateral stock, sharing 2 ETFs with FRSH. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 5 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
FRSH Ownership Dynamics
ETFs with Highest FRSH Exposure
Float lock-up computed from 5 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
FRSH Capital Efficiency
How efficiently does FRSH convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
FRSH converts 560% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. However, the ROIC-WACC spread is negative (-9.2%), suggesting reinvested capital is destroying shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-07 | 6 | $8.89 | $53.34 |
| 2026-05-06 | 1,023 | $9.19 | $9,401.37 |
| 2026-04-30 | 419,134 | $8.25 | $3.5M |
| 2026-04-14 | 224 | $7.89 | $1,767.36 |
| 2026-04-10 | 1,072 | $7.94 | $8,511.68 |
| 2026-04-09 | 368 | $8.04 | $2,958.72 |
| 2026-03-31 | 1,878 | $8.04 | $15,099.12 |
| 2026-03-23 | 1,855 | $8.03 | $14,895.65 |
| 2026-03-09 | 209 | $8.63 | $1,803.67 |
| 2026-03-02 | 11,584 | $7.82 | $90,586.88 |
| 2026-02-23 | 200 | $7.46 | $1,492 |
| 2026-01-30 | 1,458 | $10.64 | $15,513.12 |
| 2026-01-26 | 6,543 | $11.84 | $77,469.12 |
| 2025-12-31 | 1,883 | $12.33 | $23,217.39 |
| 2025-12-22 | 1,250 | $12.53 | $15,662.5 |
| 2025-12-01 | 100 | $12.14 | $1,214 |
| 2025-11-07 | 2,328 | $10.85 | $25,258.8 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare FRSH to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.